[go: up one dir, main page]

IE861411L - Spiro-imidazolidines as aldose reductase inhibitors - Google Patents

Spiro-imidazolidines as aldose reductase inhibitors

Info

Publication number
IE861411L
IE861411L IE141186A IE141186A IE861411L IE 861411 L IE861411 L IE 861411L IE 141186 A IE141186 A IE 141186A IE 141186 A IE141186 A IE 141186A IE 861411 L IE861411 L IE 861411L
Authority
IE
Ireland
Prior art keywords
imidazolidines
spiro
reductase inhibitors
aldose reductase
aldose
Prior art date
Application number
IE141186A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IE141186A priority Critical patent/IE861411L/en
Publication of IE861411L publication Critical patent/IE861411L/en

Links

IE141186A 1986-05-28 1986-05-28 Spiro-imidazolidines as aldose reductase inhibitors IE861411L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE141186A IE861411L (en) 1986-05-28 1986-05-28 Spiro-imidazolidines as aldose reductase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE141186A IE861411L (en) 1986-05-28 1986-05-28 Spiro-imidazolidines as aldose reductase inhibitors

Publications (1)

Publication Number Publication Date
IE861411L true IE861411L (en) 1986-11-29

Family

ID=11026786

Family Applications (1)

Application Number Title Priority Date Filing Date
IE141186A IE861411L (en) 1986-05-28 1986-05-28 Spiro-imidazolidines as aldose reductase inhibitors

Country Status (1)

Country Link
IE (1) IE861411L (en)

Similar Documents

Publication Publication Date Title
EP0251625A3 (en) Novel hmg-coa reductase inhibitors
GR862006B (en) Novel hmg-coa reductase inhibitors
EP0457803A4 (en) 4-hydroxythiazoles as 5-lipoxygenase inhibitors
PH27278A (en) Spiro-isoquinoline-pyrrolidine tetrones useful as aldose reductase inhibitors
EP0241043A3 (en) Novel diarylalkanoids having activity as lipoxygenase inhibitors
IE893363L (en) Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof¹useful as aldose reductase inhibitors
EP0421365A3 (en) Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity
ZW9087A1 (en) Dopamine-b-hydroxylase inhibitors
AU6593090A (en) Novel pyridyloxyazole-2-ones useful as proteinkinase c inhibitors
ZA872334B (en) Modified enzyme
GB2188047B (en) Aldose reductase inhibitor
EP0266779A3 (en) Scale inhibitor
EP0429038A3 (en) Xanthine oxidase inhibitor
ZA889708B (en) 1-aralkyl-2 mercaptoimidazolines as dopamine-beta hydroxylase inhibitors
IE861411L (en) Spiro-imidazolidines as aldose reductase inhibitors
ZA851426B (en) 17 beta-n-monosubstituted carbamoyl-4-aza-5 alpha-androst-1-en-3-ones as 5 alpha reductase inhibitors
ZA874487B (en) Novel hmg-coa reductase inhibitors
GB8610670D0 (en) Enzyme
ZA863425B (en) 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
GB8613430D0 (en) Enzyme
ZA897929B (en) Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
IE870041L (en) Heterocyclic aldose reductase inhibitors
IE861739L (en) Hmg-coa reductase inhibitors
GB2186137B (en) Amplifying arrangements
GB8919736D0 (en) Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibators